In contrast to favorable cure rates in childhood acute lymphoblastic leukemia, prognosis in infant leukemia occurring within the first year of life remained poor, despite intense effort in therapy optimization in this critical subgroup. The early clinical manifestation, detection of leukemic clonespecific gene rearrangements in neonatal blood spots and high concordance rates in monochorial twins argue for a prenatal origin in most, if not all cases of infant leukemia. 1 A hallmark of infant leukemia is the high prevalence of chromosomal rearrangements involving the MLL gene at chromosome band 11q23, detectable in about two-thirds of cases. The most frequent partner genes are AF4 (MLLT2), AF9 (MLLT4) and ENL (MLLT3), accounting for B85% of all MLL-positive cases. 2 With respect to clinical course and biological features, infant leukemia exhibits different characteristics to a phenotypically and cytogenetically similar disease in older age. 3, 4 A high rate of breakpoints located in the telomeric portion of the MLL breakpoint cluster region (BCR), similar to therapyinduced acute leukemia associated with topoisomerase II inhibitors, suggested a similar mechanism for MLL rearrangement generation in infant leukemia. Other DNA features, such as scaffold-attachment regions (SAR), DNAse I hypersensitivity sites and initiation sites of apoptotic nucleases, have been discussed to be involved in alternative break mechanisms. 1 The aim of this study was to assess breakpoint distribution within the MLL gene in a cohort of 59 infants, in comparison with pediatric and adult patients, to evaluate age-dependent breakpoint distribution and association of recombination-related sequence motifs.
Leukemic cells from infants enrolled in treatment protocols of the German and Austrian ALL-BFM 95 or the Interfant-99 study groups were analyzed. Patients' characteristics are shown in Supplementary Table 1 . Parents or legal guardians gave informed consent for treatment and DNA analysis. The distribution of MLL partner genes AF4, AF9 and ENL was similar to the allocation in the complete Interfant-99 study population. 2 Breakpoint distribution of our cohort was compared with previously published MLL-AF4, MLL-AF9 and MLL-ENL breakpoints with information of the subject's age. [5] [6] [7] [8] [9] Methods for amplification of genomic fusions are described in the Supplementary Information. Amplicons spanning chromosomal breakpoints were directly sequenced and fusion sequences were aligned to reference sequences, including the MLL, AF4, AF9 and ENL BCR (extracted from the ENSEMBL database), to define breakpoint positions for subsequent analysis.
Breakpoint clusters were defined as regions in which lower limit of 95% confidence band, determined by bootstrapping procedure, are higher than upper limit of 95% confidence band of density functions resulting from simulations at randomly distributed pseudo-breakpoints. Further details of statistical methods for breakpoint density and cluster analysis by scan statistics are given in the Supplementary Material.
The genomic fusion sites from 59 infant MLL samples (33 MLL-AF4, 10 MLL-AF9 and 16 MLL-ENL) were all located in the MLL BCR between exon 8 and 14. Within the BCR, Kernel density analysis showed a bimodal distribution with maximum breakpoint density around position 3327 and 5681 for the total group (Figure 1a) , as well as for the MLL-AF4 subgroup (Figure 1b ). This pattern was confirmed by inclusion of 41 additional breakpoint sequences derived from previous publications 5, 7 ( Figure 1a) . A similar breakpoint distribution is reflected in the MLL-AF9 and MLL-ENL subgroups, but is less significant owing to smaller sample numbers (Supplementary Figure S1) .
Out of over 60 known partner genes, AF4 is the most frequent MLL fusion partner in both pediatric and adult acute lymphoblastic leukemia (ALL). If the same genetic mechanism were active in double-strand break initiation and repair, generating MLL-AF4 fusions in all age groups, similar breakpoint distributions should be assumed. Adult MLL-AF4 breakpoints show a marked clustering in the centromeric part of the MLL BCR (Figure 1b) . In previous reports, on the basis of smaller sample numbers (n ¼ 24) and illustration of breakpoint distribution in categorized histogram intervals, a unimodal biased distribution toward the telomeric part of the MLL BCR was suggested for infant MLL-AF4 fusion sites. 5 However, representation of breakpoint distribution after Kernel density analysis of the more extended cohort of this study showed the presence of two major breakpoint clusters in infant leukemia, with 17 of 33 (52%) of breakpoints within the centromeric cluster previously considered indicative for adult leukemia (Figure 1b) .
MLL breakpoint positions showed an age-dependent distribution. The bimodal distribution of MLL-AF4 breakpoints in infants switched to a centromeric distribution similar to adult leukemia between the ages of 1 and 10 years. The difference between infant and adult breakpoint distribution is statistically significant. In contrast, AF4 breakpoint positions show no age dependency. There is no positional association between MLL and partner gene fusion site (Figure 2 Letters to the Editor presence of a telomeric breakpoint cluster similar to therapyrelated leukemia (Figure 1b) . The latter cluster around position 6590 is strongly associated to an experimentally validated topoisomerase II recognition site (Figure 1c) . 6 In contrast to therapy-related leukemia and a minor break cluster in adult leukemia, the topoisomerase II site colocalizes exactly only with a smaller fraction of fusion sites, whereas the main peak of telomeric breakpoints in infants is shifted toward the centromere. However, the bimodal breakpoint distribution containing about half of all breaks at the margin of a strong SAR in MLL supports a contribution of SAR-related chromosomal breakage in the generation of MLL translocations (Figures 3a and c) . SAR are sequences in which eukaryotic DNA is anchored to the central scaffold of the chromosome. A similar colocalization of a SAR and breakpoint cluster has been shown for the MLL fusion partner gene AF9.
11 A recent summary of a large collection of MLL rearranged ALL and acute myeloid leukemia cases, including rare fusion partners, confirmed the preference for recombination events affecting MLL intron 11 in pediatric ALL; however, infants have not been analyzed separately in this study. 12 In balanced translocations, tracing the final breakpoint positions on the two derivative fusion sites back to the original genomic sequence indicates the window within which the initial breakage likely occurred. Breakpoint analysis from a subset of cases sequenced for both derivative fusion sites showed various degrees of nucleotide gain and loss as a result of the nonhomologous end-joining repair process. Assuming general breakpoint initiation at the telomeric 'hot spot' followed by a variable extent of secondary processing of the free DNA ends by nucleotide resection, a continuous gradient rather than biphasic breakpoint distribution would be predicted. The observed gain or loss of breakpoint surrounding nucleotides is not different between telomeric and centromeric fusion sequences (Figure 3b ). Contribution of a selection effect due to functional consequences of exon composition does not seem likely, as both regions of maximal as well as the interval of minimal breakpoint density are located within the same intron.
The biphasic breakpoint distribution may only be partially attributable to prenatal exposure to environmental topoisomerase II inhibitors and considered an indication for additional MLL break initiation mechanisms involved in infant ALL. 
